Rohit Singh

5PUBLICATIONS
2CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)AutoimmunityPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|May 10, 2024
Beyond the CAR T Cells: TIL Therapy for Solid Tumors.

Rohit Singh

|Jan 03, 2024
4-1BB immunotherapy: advances and hurdles.

Rohit Singh, Young-Ho Kim, Sang-Jin Lee

|Jun 26, 2023
4-1BB-4-1BBL cis-interaction contributes to the survival of self-reactive CD8+ T cell.

Eunjung Cho, Rohit Singh, Chungyong Han

|Sep 02, 2020
Chronic activation of 4-1BB signaling induces granuloma development in tumor-draining lymph nodes that is detrimental to subsequent CD8+ T cell responses.

Seon-Hee Kim, Rohit Singh, Chungyong Han

|Dec 25, 2019
Siglec1-expressing subcapsular sinus macrophages provide soil for melanoma lymph node metastasis.

Rohit Singh, Beom K Choi

Pageof 1

Frequent Collaborators

1 joint publications

Beom K Choi

1 joint publications

Dong Hoon Shin